Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01078285 · ClinicalTrials.gov registry record
Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor
A clinical trial, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.
- Completed
- Registry status
- 500
- Enrollment target
NCT01078285 is a clinical trial that has completed, run by Pfizer's Upjohn has merged with Mylan to form Viatris. The registered enrollment target is 500 participants.
The verdict
NCT01078285 has completed, sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris.
- COMPLETED
- Registry status
- 500 participants
- Enrollment target
Study Summary
Despite extensive reports of the benefits of statins in reducing serious cardiovascular events such as stroke and heart disease in patients with elevated LDL-cholesterol, patients do not take their medicines regularly as prescribed. Reasons include forgetfulness, lack of understanding of the seriousness of the disease, and fear of side effects. An intervention strategy comprising 3-5 minutes of counseling, emotional support and cost-sharing may be motivational and improve adherence to treatment.
Interventions
- BEHAVIORAL Adherence Counseling
- BEHAVIORAL No Patient Counseling
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2010-03 |
| Est. Completion | 2011-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01078285
The ClinicalTrials.gov registry entry for NCT01078285 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pfizer's Upjohn has merged with Mylan to form Viatris, which has 158 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Adherence Counseling is the first listed.
NCT01078285 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01078285 about?
NCT01078285 is a clinical study titled "Effectiveness Of A Program That Includes Counseling And Patient Support On Adherence To Treatment With Lipitor". Despite extensive reports of the benefits of statins in reducing serious cardiovascular events such as stroke and heart disease in patients with elevated LDL-cholesterol, patients do not take their medicines regularly as prescribed. Reasons include forgetfulness, lack of understanding of the serious...
What is the current status of trial NCT01078285?
This trial is currently completed. The enrollment target is 500 participants. The study started on 2010-03. Estimated completion is 2011-11.
What interventions are being tested in trial NCT01078285?
The interventions under investigation include: Adherence Counseling (BEHAVIORAL), No Patient Counseling (BEHAVIORAL).
Who is sponsoring clinical trial NCT01078285?
This trial is sponsored by Pfizer's Upjohn has merged with Mylan to form Viatris, which has 158 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.